The Syk inhibitor R406 is a modulator of P-glycoprotein (ABCB1)-mediated multidrug resistanceGeorge E. Durán(Stanford University), Branimir I. Šikić(Stanford University)PLoS ONEJanuary 22, 201910.1371/journal.pone.0210879Cited by 4SaveCiteExport RISWatch citationsRelated PapersFunctional Network Analysis Reveals Extended Gliomagenesis Pathway Maps and Three Novel MYC-Interacting Genes in Human Gliomas|Cancer Research|2005|312Decreased levels of baseline and drug-induced tubulin polymerisation are hallmarks of resistance to taxanes in ovarian cancer cells and are associated with epithelial-to-mesenchymal transition|British Journal of Cancer|2017|47